Quick Answer
ABBOTT LABORATORIES reported Total Revenue of $44.33 billion for fiscal year 2025.
ABBOTT LABORATORIES Total Revenue — Annual History
| Fiscal Year | Total Revenue | YoY Change |
|---|---|---|
| 2025 | $44.33B | +5.7% |
| 2024 | $41.95B | +4.6% |
| 2023 | $40.11B | -8.1% |
| 2022 | $43.65B | +1.3% |
| 2021 | $43.08B | +24.5% |
| 2020 | $34.61B | +8.5% |
| 2019 | $31.90B | +4.3% |
| 2018 | $30.58B | +11.6% |
| 2017 | $27.39B | +31.3% |
| 2016 | $20.85B | +2.2% |
| 2015 | $20.41B | +0.8% |
| 2014 | $20.25B | +3.0% |
| 2013 | $19.66B | +3.2% |
| 2012 | $19.05B | -11.0% |
| 2011 | $21.41B | -39.1% |
| 2010 | $35.17B | +14.3% |
| 2009 | $30.76B | +4.2% |
| 2008 | $29.53B | +13.9% |
| 2007 | $25.91B | — |
Quarterly Total Revenue
| Quarter Ending | Total Revenue | YoY | QoQ |
|---|---|---|---|
| September 30, 2025 | $11.37B | +6.9% | +2.0% |
| June 30, 2025 | $11.14B | +7.4% | +7.6% |
| March 31, 2025 | $10.36B | +4.0% | -2.6% |
| September 30, 2024 | $10.63B | +4.9% | +2.5% |
| June 30, 2024 | $10.38B | +4.0% | +4.1% |
| March 31, 2024 | $9.96B | +2.2% | -1.8% |
| September 30, 2023 | $10.14B | -2.6% | +1.7% |
| June 30, 2023 | $9.98B | -11.4% | +2.4% |
- ABBOTT LABORATORIES showed an increase of +5.7% in Total Revenue compared to the prior fiscal year.
- Over the 2007–2025 period, ABBOTT LABORATORIES’s total revenue has grown by 71.1% (from $25.91 billion to $44.33 billion).
- The most recent figure is from ABBOTT LABORATORIES’s fiscal year 2025 report (Form 10-K), filed with the SEC on February 20, 2026.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: